Teva Pharmaceuticals (TEVA), and Sanofi (SNY) presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-2 ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

That reminds us of the use of holding a more value-minded portfolio alongside such a fund, and in Europe the most obvious pick here tends to be Lightman European. The portfolio made 11 per cent in ...

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.

The FDA granted orphan designation to Sanofi ( SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on TheFly – ...

Seasonal flu vaccines need to be updated each year because the virus changes so frequently. But the U.S. hasn't contributed ...

This little-known artificial intelligence growth stock is backed by chipmaker Nvidia and recently jumped nearly 24% in a ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

Kelso Pharma, the British specialty pharma business backed by Apposite Capital, today announced the acquisition of the UK ...

Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

Advisers scored lucrative roles on deals in 2024 including Sanofi’s consumer healthcare sale and the take-private of UK cyber ...